Expression of PIM-2 and NF-κB genes is increased in patients with acute myeloid leukemia (AML) and acute lymphoblastic leukemia (ALL) and is associated with complete remission rate and overall survival

Journal Title: Advances in Hygiene and Experimental Medicine - Year 2013, Vol 67, Issue 0

Abstract

Introduction: PIM-2 is a proto-oncogene that encodes for a serine/threonine kinase that interacts with various signaling molecules. PIM-2 is highly expressed in neoplastic tissues and in leukemic and lymphoma cell lines, which is consistent with its role during oncogenic transformation. The nuclear factor kappa B (NF-κB) pathway appears to be deregulated in a variety of tumors, with sustained activity of NF-κB leading to apoptotic resistance in tumor cells. The aim of this study was to investigate whether expression of PIM-2 and NF-κB is altered in acute myeloid leukemia (AML) and acute lymphoblastic leukemia (ALL).Patients and methods: One hundred forty-three patients were included: 91 with AML and 52 with ALL, aged 18-84 (median 46.7). Eighty-three patients (51 AML and 32 ALL) reached complete remission (CR). Bone marrow samples were collected at the time of diagnosis. Control samples were obtained from 24 healthy donors. We analyzed PIM-2 and NF-κB expression by RQ-PCR analysis.Results: Expression of both PIM-2 and NF-κB in all leukemia patients and subgroups was significantly higher than in controls. AML patients who reached CR expressed PIM-2 and NF-κB at significantly lower levels than did patients with primary resistance to chemotherapy and who did not reach CR (NCR). Survival analysis revealed that in AML patients with higher expression of PIM-2 the overall survival (OS) was significantly shorter than in patients with lower expression.Conclusion: Our data indicate that PIM-2 and NF-κB gene expression is increased in patients with AML and ALL. Moreover, high PIM-2 expression is associated with CR rate and OS in AML patients.

Authors and Affiliations

Katarzyna Kapelko-Słowik, Donata Urbaniak-Kujda, Dariusz Wołowiec, Bożena Jaźwiec, Jarosław Dybko, Jacek Jakubaszko, Mirosław Słowik, Kazimierz Kuliczkowski

Keywords

Related Articles

Identification of environmental Actinobacteria representing an occupational health risk

Actinobacteria, the etiologic agents of tuberculosis, actinomycosis, respiratory infections and pathological skin lesions, are also classified as hazardous biological agents at the workplace. An increased number of Actin...

HPV Vaccinations in Lublin Region, Poland

Introduction: Secondary prophylaxis of cervical cancer consisting in cytology screening tests, despite its effectiveness, does not achieve the desired results. For several years, primary prophylaxis has been available in...

The role of bile acids in the pathogenesis of bowel diseases

Bile acids not only play a cardinal role in the digestion and absorption of fat and fat-soluble vitamins, but also significantly affect gastrointestinal motor, sensory and secretory functions, intestinal barrier permeabi...

Cryoglobulinemia and its correlation with clinical extrahepatic manifestations in chronic hepatitis C

Cryoglobulinemia is a condition with a confirmed relationship with HCV infection, but many other extrahepatic symptoms are also present in hepatitis C. Aim: The aim of this study was to assess the incidence and type of e...

Rola zapalenia w patogenezie raka jelita grubego

Wyniki najnowszych badań, w co raz większym stopniu wiążą rozwój nowotworu z przewlekłym zapaleniem. Proces zapalny tworzy mikrośrodowisko sprzyjające rozwojowi nowotworów, w efekcie wiele z nich rozwija się w miejscach,...

Download PDF file
  • EP ID EP66957
  • DOI -
  • Views 157
  • Downloads 0

How To Cite

Katarzyna Kapelko-Słowik, Donata Urbaniak-Kujda, Dariusz Wołowiec, Bożena Jaźwiec, Jarosław Dybko, Jacek Jakubaszko, Mirosław Słowik, Kazimierz Kuliczkowski (2013). Expression of PIM-2 and NF-κB genes is increased in patients with acute myeloid leukemia (AML) and acute lymphoblastic leukemia (ALL) and is associated with complete remission rate and overall survival . Advances in Hygiene and Experimental Medicine, 67(0), 553-559. https://www.europub.co.uk/articles/-A-66957